您使用提示模式 关闭

517120 - Huatai-PB CSI SH-HK-SZ Brand Name Drug Industry ETF (CNY) (CNE100004V42)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

全选 清除所有
 
(%)
CNE100004V42
517120 ISIN
交易所交易基金 (ETF)
基金类型
Huatai-PineBridge Fund Management
提供商
-
每股资产净值
2021-07-08
成立日期
1 每年的次数
股息的支付
CEOXXX
CFI
517120
代码
Formed
Status
Equity
投资项目
Healthcare
部门
China
地区分布
CSI SH-HK-SZ Brand Name Drug Industry
基准
0.6 %
总成本比率
Physical
复制方法
否
UCITS
Passive (Index)
Management Style

最新数据在
添加比较项目
从
至
ADD-IN
Cbonds 加载项 API
债券数据 API

报价 (517120)

探索最全面的数据库

1 000 000

债券

80 234

股票

167 970

ETF & Funds

8万

指数

以最有效的方式跟踪您的投资组合

  • 债券筛选器
  • 观察列表
  • Excel 附加组件
请求访问

价格动态的变化

Fund profile

The Huatai-PB CSI SH-HK-SZ Brand Name Drug Industry ETF seeks to replicate as closely as possible the price and yield performance of the CSI SH-HK-SZ Brand Name Drug Industry Index by investing in a portfolio comprised primarily of Chinese companies

517120 profile

The Huatai-PB CSI SH-HK-SZ Brand Name Drug Industry ETF (CNY) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Healthcare sector located in China. The Huatai-PineBridge Fund Management fund’s base currency is CNY and the share class was registered 08.07.2021 with unique ISIN - CNE100004V42. Main exchange is Shanghai SE and ticker symbol is 517120. The total expense ratio is 0.6%. The Huatai-PB CSI SH-HK-SZ Brand Name Drug Industry ETF (CNY) pays dividends 1 time(s) per year.

其他 ETF 和基金提供商

相关 ETF 和基金

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} 百万
    资产净值
    {{ item.expense_ratio }}
    总成本比率
你必须 注册 才能获得访问权